Log in or Sign up for Free to view tailored content for your specialty!
Inflammatory Bowel Disease News
Amjevita leads Humira biosimilars in clinician comfort as rheumatologists remain wary
Only half of rheumatologists are “extremely comfortable” prescribing the Humira biosimilar Amjevita, while just 16% can say the same for all other adalimumab biosimilars combined, according to a market analysis from Spherix Global Insights.
Better efficacy outcomes associated with infliximab vs. vedolizumab in Crohn’s disease
Induction and maintenance treatment with infliximab was more efficacious than vedolizumab in patients with Crohn’s disease, while efficacy was similar between the two therapies in patients with ulcerative colitis, according to data.
Log in or Sign up for Free to view tailored content for your specialty!
Female sex, genetics, smoking status linked to extraintestinal manifestation in IBD
Female sex, smoking, Crohn’s disease and a history of surgery to treat inflammatory bowel disease were associated with an increased risk for developing extraintestinal manifestations of disease, according to research in Gastroenterology.
Rinvoq 45 mg prompts ‘rapid resolution’ of Crohn’s disease symptoms as early as day 5
Once-daily Rinvoq 45 mg provided “rapid relief” of stool frequency and abdominal pain score within the first week of induction therapy in patients with moderately to severely active Crohn’s disease, according to a data analysis.
Source of surging autoimmunity may lie in ‘a thousand cuts’
The common consensus for some time has been that the prevalence of autoimmunity and autoimmune diseases has been on the rise.
‘Case appears clearcut’: Top-down therapy should be ‘standard of care’ for new Crohn’s
Early treatment with infliximab plus an immunomodulator resulted in more frequent steroid-free and surgery-free remission at 1 year compared with conventional therapy among patients with newly diagnosed Crohn’s disease, researchers reported.
VIDEO: Roundtables invite young adults with IBD to ‘have equal voices’ on research, care
In a Healio video exclusive, Sneha Dave, recaps a roundtable series presented by the Crohn’s and Colitis Young Adults Network, which encourages young adults with inflammatory bowel disease to discuss gaps and opportunities in research.
VIDEO: Inflammation likely ‘driving the risk’ for cardiovascular events in IBD
In a Healio video exclusive, Edward V. Loftus Jr., MD, discusses data he presented at the GUILD Conference, which show patients with inflammatory bowel disease are at increased risk for cardiovascular events, likely driven by inflammation.
AGA: ‘We must work together’ to alleviate barriers, improve care for patients with IBD
A 12-point plan from the AGA proposed ways in which collaboration between the health care community, insurers, pharmaceutical companies and legislators can improve “fixable problems” affecting patients with inflammatory bowel disease.
No spondyloarthritis screening tools generalizable to all at-risk patients
Screening patients with psoriasis, uveitis or inflammatory bowel disease for spondyloarthritis could improve early diagnosis, but no existing screening tools are generalizable to all who are at risk, according to a scoping review.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read